Search clinical trials for: Eribulin
Total 214 results
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)RecruitingBreast Cancer | Breast NeoplasmsUnited States
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
Virginia G. KaklamaniEisai Inc.Completed
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Canada, France, Italy, Spain, United Kingdom, Hungary, Poland, United States, Korea, Republic of, Brazil, India, Japan, Russian Federation, China, Taiwan, Netherlands, Germany, South Africa, Argentina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.TerminatedTriple Negative Breast CancerChina
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerChina, United States, Spain, Hungary, Israel, Korea, Republic of, Taiwan, Belgium, Austria, Russian Federation, Switzerland, Portugal, France, Canada, Italy, United Kingdom, Greece, Japan, Germany, Sweden
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals; ETOP IBCSG Partners Foundation; Breast International...Active, not recruitingAdvanced Breast CancerSpain, Netherlands, France, Italy, Austria, Switzerland
-
OHSU Knight Cancer InstituteOregon Health and Science University; Eisai Inc.Active, not recruitingMalignant Solid Neoplasm | Liposarcoma | Malignant Abdominal Neoplasm | Malignant Retroperitoneal Neoplasm | Malignant Scrotal Neoplasm | Malignant Spermatic Cord NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Eisai Inc.CompletedPrimary Brain Tumor | Metastatic Malignant Neoplasm in the Adult BrainUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma and other conditionsUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
SCF PharmaIntegrated Health and Social Services Centres (CISSS) de la Gaspésie; Integrated...Completed
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruitingSarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic SarcomaUnited States
-
MedSIRHoffmann-La RocheCompletedTriple Negative Breast CancerSpain, Portugal
-
M.D. Anderson Cancer CenterActive, not recruitingBreast Inflammatory Carcinoma | Recurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
Otsuka Beijing Research InstituteCompleted
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Dana-Farber Cancer InstituteCompleted
-
Otsuka Beijing Research InstituteCompleted
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Active, not recruitingTriple Negative Breast CancerChina
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)SuspendedInvasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Eisai Co., Ltd.CompletedInoperable or Recurrent Breast CancerJapan
-
Eisai LimitedCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Fujian Cancer HospitalActive, not recruiting
-
Eisai Inc.CompletedBreast Cancer | Estrogen Receptor Positive TumorUnited States
-
Eisai Inc.CompletedBreast CancerUnited States
-
Eisai Inc.Completed
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
Eisai Inc.Quintiles, Inc.CompletedNon Small Cell Lung CancerUkraine, Germany, United States, Italy, Czechia
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
Eisai Inc.CompletedSoft Tissue SarcomaUnited States, France, United Kingdom, Germany, Spain, Belgium, Argentina, Israel, Poland, Romania, Korea, Republic of, Canada, Netherlands, Australia, New Zealand, Singapore, Brazil, Russian Federation, Austria, Thailand, Italy, ... and more
-
Eisai Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Taiwan, Hong Kong, Spain, Poland, Singapore, Russian Federation, Italy, Australia, France, Germany, Japan, United Kingdom, Korea, Republic of
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLC; National Institutes of Health (NIH)CompletedCardiovascular Diseases | Hepatitis C | HivUnited States
-
Consorzio OncotechActive, not recruitingMetastatic Breast CancerItaly
-
Nektar TherapeuticsCompletedBreast Cancer | MetastasisUnited States, Australia, Belgium, Canada, France, Israel, Italy, Portugal, Spain, United Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityActive, not recruiting
-
Massachusetts General HospitalEisai Inc.Active, not recruitingAngiosarcoma | Epithelioid HemangioendotheliomaUnited States
-
MedSIRWithdrawn